Skip to main content

Day: March 9, 2021

Checkpoint Therapeutics Reports Full-Year 2020 Financial Results and Recent Corporate Highlights

NEW YORK, March 09, 2021 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the full-year ended December 31, 2020 and recent corporate highlights.James F. Oliviero, President and Chief Executive Officer of Checkpoint, said, “We are very pleased with our momentum throughout 2020, solidifying the registration path for cosibelimab in metastatic cutaneous squamous cell carcinoma (“mCSCC”), as well as announcing positive interim data from our pivotal Phase 1 program. Checkpoint’s registration-enabling study in mCSCC is approximately 90% enrolled, with full enrollment anticipated shortly. We remain on track to report full top-line results in the second half of 2021. With a potentially favorable safety profile...

Continue reading

iBio to Participate in the 33rd Annual Roth Conference

BRYAN, Texas, March 09, 2021 (GLOBE NEWSWIRE) — iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced that it will participate in the 33rd Annual Roth Conference, which will be held virtually from March 15-17, 2021.iBio’s pre-recorded presentation will be available on demand during the virtual event for all registered attendees. Beginning on Monday, March 15, 2021, the presentation will also be available on the Company’s website at www.ibioinc.com under “News & Events” in the Investors section.About iBio, Inc.iBio is a global leader in plant-based biologics manufacturing. Its FastPharming® System combines vertical farming, automated hydroponics, and novel glycosylation technologies to rapidly deliver high-quality monoclonal...

Continue reading

DeFi Technologies Closes $10 Million Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, March 09, 2021 (GLOBE NEWSWIRE) — DeFi Technologies Inc. (the “Company” or “DeFi”) (NEO: DEFI, GR: RMJR) is pleased to announce that it has closed the previously announced non-brokered private placement financing of an aggregate of 5,000,000 common shares of the Company (each a “Common Share”) at a price of C$2.00 per Common Share for gross proceeds of C$10,000,000 (the “Offering”). DeFi intends to use the proceeds of the Offering for potential investment opportunities in the decentralized finance industry and general corporate purposes.In connection with the Offering, the Company has paid aggregate finder’s fees of C$274,120 in cash to certain finders. The securities issued under the Offering are subject to a statutory hold...

Continue reading

AirBoss Announces Record 4th Quarter and Full Year 2020 Results and Ongoing Momentum

NEWMARKET, Ontario, March 09, 2021 (GLOBE NEWSWIRE) — AirBoss of America Corp. (TSX: BOS) (the “Company” or “AirBoss”) today announced record fourth quarter and annual performance as it enters 2021 with strong momentum. The Company will host a conference call and webcast to discuss the results on March 10th at 9 a.m. ET, the details of which are further below.Recent Highlights($US except where otherwise noted)Grew net sales by  54.1% for the fourth quarter of 2020 (“Q4 2020”) to $132.2 million vs $85.8 million in the fourth quarter of 2019 (“Q4 2019”), and by 52.9% to $501.6 million in 2020 vs $328.1 million in 2019;Increased Adjusted EBITDA by 259.6% to $32.8 million in Q4 2020 vs $9.1 million in Q4 2019, and by 228.0% to $105.6 million in 2020 vs $32.2 million in 2019;Grew diluted EPS by 436.4% to $0.59 in Q4 2020 (Q4 2019: $0.11),...

Continue reading

ERYTECH Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F

ERYTECH Announces Filing of2020 Universal Registration Document and2020 Annual Report on Form 20-FLyon (France) and Cambridge, MA (U.S.), March 9, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, announced that it had filed its 2020 Universal Registration Document for the year ended December 31, 2020, including the management report and the annual financial report with the “Autorité des Marchés Financiers (AMF)” and its Annual Report on Form 20-F for the year ended December 31, 2020 with the U.S. Securities and Exchange Commission (SEC).These documents can be accessed on the Investors section of the Company’s corporate website (wwww.erytech.com). In addition, the Universal Registration Document...

Continue reading

Texas Capital Bancshares, Inc. Announces Steps to Enhance the Company’s Balance Sheet

Closes Credit Risk Transfer Transaction with World-Class Institutional InvestorsPreviously Launched Series B Preferred Stock to Raise Additional CapitalTransactions Optimize Balance Sheet and Provide Greater Capacity to Support Best-In-Class Mortgage Finance Offerings Through Multiple CyclesDALLAS, March 09, 2021 (GLOBE NEWSWIRE) — Texas Capital Bank, N.A., and its parent company Texas Capital Bancshares, Inc. (NASDAQ: TCBI), collectively referred to herein as “Texas Capital Bank,” today announced the closing of a Credit Risk Transfer (CRT) transaction with institutional investors. The CRT is an important step forward in Texas Capital Bank’s proactive efforts to optimize its balance sheet and support its best-in-class Mortgage Finance offerings through multiple cycles. The transaction enables the Company to expand the Warehouse...

Continue reading

ABM Industries Announces Results for First Quarter Fiscal 2021

GAAP Continuing EPS of $1.10; Adjusted Continuing EPS of $1.01Cash Flow from Operations of More Than $45 MillionFiscal 2021 Guidance Outlook IssuedDeclaration of 220thConsecutive Quarterly DividendNEW YORK, March 09, 2021 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility solutions, today announced financial results for the first quarter of fiscal 2021.Scott Salmirs, President and Chief Executive Officer of ABM Industries commented, “Our strong performance for the first quarter underscores our clients’ focus on protecting their people and spaces. Revenue performance exceeded our expectations as we saw an acceleration of higher margin, Work Orders for virus protection and EnhancedClean™ services. Effective labor management also remained a critical component of our results as we navigated the hybrid occupancy environment...

Continue reading

Auburn National Bancorporation Authorizes Stock Repurchase Program

AUBURN, Ala., March 09, 2021 (GLOBE NEWSWIRE) — Auburn National Bancorporation, Inc. (NASDAQ: AUBN) announced today that the Company’s Board of Directors has approved a new stock repurchase program to replace the repurchase program that expires on March 31, 2021. The new program authorizes the repurchase, from time to time, of up to $5 million of the Company’s issued and outstanding common stock through March 2022. The stock repurchases may be open-market or private purchases, negotiated transactions, block purchases, and otherwise.The Company is not required to acquire any specific number of shares and may suspend or terminate its share repurchases at any time. The amount and timing of the stock repurchases will be based on various factors, such as management’s assessment of the Company’s liquidity, the market price of Company...

Continue reading

Farmer Brothers Announces Participation at Roth’s 33rd Annual Investor Conference & Release Date for Investor Presentation

NORTHLAKE, Texas, March 09, 2021 (GLOBE NEWSWIRE) — Farmer Bros. Co. (NASDAQ: FARM) (the “Company”), a leading national coffee roaster, wholesaler, equipment servicer, and distributor of coffee, tea, and culinary products, today announced its attendance at Roth’s 33rd Annual Investor Conference on March 15th, 16th, and 17th.The Company will be hosting virtual one-on-one meetings over the three days. In conjunction with the event, the Company will post an updated Investor Presentation on the Company’s website at www.farmerbros.com under “Investor Relations” on the morning of the 15th.If you are attending the conference and would like to request a one-on-one meeting with management, please do so through the conference portal.About Farmer BrothersFounded in 1912, Farmer Bros. Co. is a national coffee roaster, wholesaler, equipment...

Continue reading

ANGI Monthly Metrics Available on IAC IR Site

NEW YORK, March 09, 2021 (GLOBE NEWSWIRE) — IAC (NASDAQ: IAC) posted monthly metrics for February 2021, including metrics for ANGI Homeservices Inc. (NASDAQ: ANGI), on the investor relations section of the IAC website at https://ir.iac.com/.About ANGI Homeservices Inc.ANGI Homeservices Inc. (NASDAQ: ANGI) turns home improvement jobs imagined into jobs well-done. People throughout North America and Europe rely on us to book quality home service pros across 500 different categories, from repairing and remodeling to cleaning and landscaping. Nearly 250,000 domestic service professionals actively seek consumer matches, complete jobs or advertise through ANGI Homeservices’ platforms and consumers turned to at least one of our brands to find a pro for more than 30 million projects last year. We’ve established category-transforming products...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.